An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
Titel:
An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
Auteur:
Spicer, J. Provencio, M. Garrido Lopez, P. Bosch-Barrera, J. de Castro CarpeƱo, F.J. Felip, E. Trigo, J. Viteri, S. Coart, E. Schmidt, E. Christiansen, A.V. Zocca, M.-B. Andersen, M.H. Ehrnrooth, E. Paz-Ares, L.